Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331:596 (17 September), doi:10.1136/bmj.331.7517.596
Janice Hopkins Tanne
New York
Janice Hopkins Tanne looks at why emergency contraception is proving so controversial in the United States, even though it is now available without prescription in nearly 40 countries
| The first 150 words of the full text of this article appear below. |
A furore has erupted in the United States after the announcement by Dr Lester Crawford, commissioner of the Food and Drug Administration (FDA), that he was going to postpone indefinitely a decision to make emergency contraception available over the counter, even though two FDA committees have recommended such availability (
BMJ
2005;331: 532
An assistant commissioner at the FDA resigned over the issue, and 13 senators asked the independent Government Accounting Office to accelerate the investigation of the FDA's actions, which the senators had requested in June 2004.
Major newspapers from coast to coast castigated the FDA; almost none spoke in its support.
The consensus was that the FDA had abandoned science and was knuckling under to political pressure from conservatives who oppose abortion and confuse emergency contraception with abortion.
Susan Wood resigned as assistant commissioner for women's health and director of the FDA's
-->
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses